US drug approvals
5 approvals with a product on the US market
- Dexamethasone ANDA218372 · approved 17 Sep 2024
- Dicyclomine Hydrochloride ANDA216639 · approved 24 Mar 2023
- Dicyclomine Hydrochloride ANDA216760 · approved 28 Nov 2022
- Pioglitazone Hydrochloride ANDA210165 · approved 22 Jan 2021
- Ramipril ANDA079116 · approved 20 Jun 2008
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.